Suppr超能文献

五个欧洲国家哮喘治疗的差异——病例模拟的判断分析

Variations in asthma treatment in five European countries--judgement analysis of case simulations.

作者信息

Wahlström Rolf, Hummers-Pradier Eva, Lundborg Cecilia Stålsby, Muskova Maria, Lagerløv Per, Denig Petra, Oke Thimothy, de Saintonge D Mark Chaput

机构信息

Division of International Health (IHCAR), Department of Public Health Sciences, Karolinska Institutet, SE-171 76 Stockholm, Sweden.

出版信息

Fam Pract. 2002 Oct;19(5):452-60. doi: 10.1093/fampra/19.5.452.

Abstract

OBJECTIVE

The aim of this study was to explore and compare treatment decisions and the influence of specific patient characteristics on asthma management in five European countries, and to relate this to existing guidelines.

METHODS

Using the technique of clinical judgement analysis, doctors in The Netherlands, Norway, Germany, Sweden and the Slovak Republic (40-100 doctors per country) were presented with sets of written simulated cases on asthma treatment. Patient characteristics were varied to determine their influence on the doctors' decisions. Decisions indicating over- and under-prescribing in relation to a gold standard derived from guidelines were also determined.

RESULTS

Doctors in The Netherlands prescribed more oral steroid courses and fewer antibiotics than doctors in Norway and Sweden, whereas doctors in Germany and the Slovak Republic prescribed the least oral steroids and the most antibiotics. Partially, this variation could be explained by differences in the underlying propensity to prescribe, but differences in the use of patient characteristics also contributed to the variation. Norwegian doctors were most inclined to increase the maintenance treatment of inhaled corticosteroids, which could best be explained by their relatively high focus on the patient's peak expiratory flow value. Compared with the gold standard, there was 25-56% under-prescribing of oral steroids, and 21-45% over-prescribing of antibiotics.

CONCLUSIONS

The variation in treatment of asthma patients between doctors in different countries may, in part, be attributed to variations in the underlying propensity to prescribe, and in part to different use of clinical patient characteristics. These findings can be used in tailoring educational programmes to improve treatment practices.

摘要

目的

本研究旨在探讨和比较五个欧洲国家在哮喘管理方面的治疗决策以及特定患者特征的影响,并将其与现有指南相关联。

方法

采用临床判断分析技术,向荷兰、挪威、德国、瑞典和斯洛伐克共和国的医生(每个国家40 - 100名医生)提供一系列关于哮喘治疗的书面模拟病例。改变患者特征以确定其对医生决策的影响。还确定了与源自指南的金标准相比存在的处方过多和过少的决策情况。

结果

荷兰医生开出的口服类固醇疗程比挪威和瑞典医生多,抗生素比挪威和瑞典医生少,而德国和斯洛伐克共和国的医生开出的口服类固醇最少,抗生素最多。部分这种差异可以通过潜在处方倾向的不同来解释,但患者特征使用上的差异也导致了这种差异。挪威医生最倾向于增加吸入性皮质类固醇的维持治疗,这最能通过他们相对高度关注患者的呼气峰值流速来解释。与金标准相比口服类固醇处方不足25% - 56%,抗生素处方过量21% - 45%。

结论

不同国家医生对哮喘患者的治疗差异,部分可归因于潜在处方倾向的差异,部分可归因于对临床患者特征的不同使用。这些发现可用于定制教育项目以改善治疗实践。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验